Table 4.
Time to end of therapy
| Parameter | Overall cohort | Complete switch cohort | ||
|---|---|---|---|---|
| LAI (n = 1,132) | Oral (n = 1,518) | LAI (n = 533) | Oral (n = 230) | |
| Summary | ||||
| End of therapy (n) | 881 | 1378 | 420 | 190 |
| Censored, n (%) | 251 (22.2) | 140 (9.2) | 113 (21.2) | 40 (17.4) |
| Time to end of therapy (days) | ||||
| Mean (SE) | 580.6 (22) | 277 (13.5) | 558.4 (31.9) | 377.1 (32.8) |
| Median (95% CI) | 216 (193–249) | 50 (46–56) | 211 (163–247) | 119.5 (86–157) |
| Reason for end of therapy among patients whose therapy ended, n (%) | ||||
| Gap >60 days | 518 (58.8) | 543 (39.4) | 317 (75.5) | 144 (75.8) |
| Other agent taken after last prescription | 363 (41.2) | 835 (60.6) | 103 (24.5) | 46 (24.2) |
CI confidence interval, LAI long-acting injectable, SE standard error